Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| A novel cuproptosis-related diagnostic gene signature and differential expression validation in atherosclerosis. | Mol Biomed | 2023 | 37442861 | PubTator, text mining | PubMed |
| Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in temporal lobe epilepsy. | Front Pharmacol | 2023 | 37435496 | PubTator, text mining | PubMed |
| Dietary Trace Elements and the Pathogenesis of Neurodegenerative Diseases. | Nutrients | 2023 | 37432185 | PubTator, text mining | PubMed |
| Unveiling the genomic landscape of possible metastatic malignant transformation of teratoma secondary to cisplatin-chemotherapy: a Tempus gene analysis-based case report literature review. | Front Oncol | 2023 | 37427132 | PubTator, text mining | PubMed |
| Copper in cancer: from limiting nutrient to therapeutic target. | Front Oncol | 2023 | 37427098 | PubTator, text mining | PubMed |
| Diagnosis, management and genetic analysis of a cat with primary copper hepatopathy. | JFMS Open Rep | 2023 | 37427085 | PubTator, text mining | PubMed |
| Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma. | Biochem Biophys Rep | 2023 | 37426702 | PubTator, text mining | PubMed |
| Dysregulation of Copper Metabolism in a Patient With Acute-on-Chronic Liver Failure Worked up for Fulminant Wilson Disease. | ACG Case Rep J | 2023 | 37426568 | PubTator, text mining | PubMed |
| A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer. | Aging (Albany NY) | 2023 | 37424068 | PubTator, text mining | PubMed |
| Potential diagnostic biomarkers: 6 cuproptosis- and ferroptosis-related genes linking immune infiltration in acute myocardial infarction. | Genes Immun | 2023 | 37422588 | PubTator, text mining | PubMed |
| RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy. | Cell Biosci | 2023 | 37420298 | PubTator, text mining | PubMed |
| Stimulation of Liver Fibrosis by N2 Neutrophils in Wilson's Disease. | Cell Mol Gastroenterol Hepatol | 2023 | 37406734 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related lncRNA for predicting prognosis and immunotherapeutic response in cervical cancer. | Sci Rep | 2023 | 37400520 | PubTator, text mining | PubMed |
| Structural Organization of the Retriever-CCC Endosomal Recycling Complex. | Res Sq | 2023 | 37397996 | PubTator, text mining | PubMed |
| Cervical cancer: a tale from HPV infection to PARP inhibitors. | Genes Dis | 2023 | 37397551 | PubTator, text mining | PubMed |
| Niclosamide (NA) overcomes cisplatin resistance in human ovarian cancer. | Genes Dis | 2023 | 37397523 | PubTator, text mining | PubMed |
| Regulation of Atp7a RNA contributes to differentiation-dependent Cu redistribution in skeletal muscle cells. | Metallomics | 2023 | 37391383 | PubTator, text mining | PubMed |
| Impact of Cuproptosis-related markers on clinical status, tumor immune microenvironment and immunotherapy in colorectal cancer: A multi-omic analysis. | Comput Struct Biotechnol J | 2023 | 37389187 | PubTator, text mining | PubMed |
| Quality of life and depression in Wilson's disease: a large prospective cross-sectional study. | Orphanet J Rare Dis | 2023 | 37386576 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=29